west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "药疹" 6 results
  • 重症药疹伴耐甲氧西林金黄色葡萄球菌感染护理一例

    Release date:2021-06-23 07:35 Export PDF Favorites Scan
  • 丙戊酸钠致重症多形红斑型药疹一例

    Release date:2016-09-08 09:13 Export PDF Favorites Scan
  • Pharmaceutical Practice Conducted by Clinical Pharmacists for a Patient with Erythama Multiforme Drug Eruption

    目的 报道临床药师参与抗结核药物致结核性胸膜炎待诊患者多形红斑型药疹的临床药学实践的经验。 方法 1例结核性胸膜炎待诊患者在2011年11月3日出现皮疹后,临床药师根据患者的用药情况及病情变化,提供咨询意见,与临床医师共同制定不良反应的临床处理措施。 结果 推断为链霉素所致的多形红斑型药疹,积极处理后患者病情好转。 结论 临床药师参与药学监护,有利于处理药物不良反应。

    Release date:2016-09-08 09:18 Export PDF Favorites Scan
  • 别嘌醇药疹临床特点分析

    目的分析别嘌醇致药疹的临床特点。 方法对2008年1月-2012年3月就诊的15例别嘌醇致药疹患者的临床表现、实验室检查、治疗、预后进行回顾性分析。 结果别嘌醇所致药疹类型为:多形红斑型7%、重症多形红斑型4例、红皮病型2例、大疱表皮松解型1例,急性泛发性发疹型脓疱病1例,其潜伏期平均12.6 d,病情重(8例为重型药疹)、肝肾受累常见。糖皮质激素治疗有效,但治疗时间长(平均住院日28.6 d)、1例死亡。 结论别嘌醇致药疹应引起重视,治疗应用确诊后应立即使用糖皮质激素,早期、足量给药,维持较长时间,缓慢减量为宜。

    Release date: Export PDF Favorites Scan
  • 药疹患者临床类型分析及护理

    目的讨论分析药疹患者的临床类型及护理方法。 方法回顾分析 2012年 1月-12月 100例药疹患者的药疹类型及主要致敏物,并就其所实施的责任包干制整体护理方法予以总结。 结果在医护人员的精心治疗与护理下,100例患者的药疹疾患得以控制且逐步转好,住院时间(17±5)d,87% 的患者治愈,13%的患者好转出院。 结论采用责任包干制的整体护理模式,可取得较好的临床护理效果。

    Release date: Export PDF Favorites Scan
  • A clinical analysis of 48 cases of severe drug eruption

    Objective To explore the clinical features and prognosis related factors of severe drug eruption. Methods The clinical data of 48 patients with drug eruption treated between January 2010 and August 2015 were retrospectively analyzed. Results The major type of drug eruption was Stevens-Johnson syndrome (58.3%), followed by toxic epidermal necrolysis (TEN) (27.1%) and hypersensitivity syndrome (14.6%). The major allergenic drug which might cuase drug eruption was antimicrobial agent (25.0%), followed by antipyretic analgesic drug (22.9%) and antigout drug (18.8%). Carbamazepine and allopurino were the common drugs caused TEN. Conclusion It is important to give sufficient corticosteroid earlier combined with intravenous immunoglobulin for reducing mortalities of severe drug eruption.

    Release date:2017-06-22 02:01 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content